Campbell & Co Investment Adviser’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.66M Buy
18,379
+4,269
+30% +$1.46M 0.35% 35
2026
Q1
$4.96M Sell
14,110
-644
-4% -$230K 0.28% 70
2025
Q4
$4.83M Buy
14,754
+10,969
+290% +$3.48M 0.23% 103
2025
Q3
$1.07M Buy
+3,785
New +$1.1M 0.08% 401
2025
Q2
– Sell
-13,861
Closed -$4.32M – 1120
2025
Q1
$4.32M Sell
13,861
-6,789
-33% -$2M 0.33% 48
2024
Q4
$5.38M Buy
20,650
+10,857
+111% +$3.22M 0.42% 39
2024
Q3
$3.16M Buy
9,793
+7,461
+320% +$2.44M 0.24% 88
2024
Q2
$729K Buy
2,332
+98
+4% +$28.8K 0.06% 497
2024
Q1
$635K Buy
+2,234
New +$654K 0.05% 597
2023
Q4
– Sell
-1,624
Closed -$436K – 1080
2023
Q3
$436K Buy
+1,624
New +$405K 0.05% 573
2023
Q1
– Sell
-7,689
Closed -$2.02M – 791
2022
Q4
$2.02M Buy
+7,689
New +$2.06M 0.48% 7
2022
Q3
– Sell
-1,985
Closed -$483K – 697
2022
Q2
$483K Buy
+1,985
New +$486K 0.13% 286
2021
Q4
– Sell
-3,119
Closed -$663K – 609
2021
Q3
$663K Buy
+3,119
New +$718K 0.22% 142
2019
Q3
– Sell
-1,410
Closed -$260K – 590
2019
Q2
$260K Buy
+1,410
New +$252K 0.12% 354
2015
Q1
– Sell
-2,000
Closed -$319K – 194
2014
Q4
$319K Buy
+2,000
New +$312K 0.2% 152

Other funds holding AMGN

Campbell & Co Investment Adviser's AMGN Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Amgen (AMGN) stake by 30% in Q2 2026, buying an estimated $1.46M and bringing the position to 18,379 shares worth $6.66M. The position accounts for 0.35% of the portfolio, ranked #35.

Campbell & Co Investment Adviser first reported a position in AMGN in Q4 2014 and has held it in 15 quarters since. 3,163 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Campbell & Co Investment Adviser held 18,379 shares of Amgen worth $6.66M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 4,269 Amgen shares in Q2 2026, an estimated $1.46M.
  • Amgen made up 0.35% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #35 holding.
  • Campbell & Co Investment Adviser first reported a position in Amgen in Q4 2014 and has held it in 15 quarters since.
  • 3,163 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.